ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo.

Katrina Albert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.